CIRSE Clinical Practice Manual

Mahnken, Andreas H.; Seoane, Esther Boullosa; Cannavale, Allesandro; Haan, Michiel W. de; Dežman, Rok; Kloeckner, Roman; O’Sullivan, Gerard J.; Ryan, Anthony; Tsoumakidou, Georgia

doi:10.1007/s00270-021-02904-3

Cited by 38 publications

(15 citation statements)

References 94 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…CT usually confirms the diagnosis with the typical findings of a central hypodense core of fluid material surrounded by a hyperdense rim and a hypodense outer ring as a double target appearance [ 115 ]. Percutaneous drainage should be considered in the case of infected collections (abscesses and bilomas) ( Figure 4 ) [ 117 , 118 , 119 ], when a worsening of laboratory and clinical parameters occurs despite antibiotic therapy.…”

Section: Complicationsmentioning

confidence: 99%

Imaging Features of Post Main Hepatectomy Complications: The Radiologist Challenging

et al. 2022

View full text Add to dashboard Cite

In the recent years, the number of liver resections has seen an impressive growth. Usually, hepatic resections remain the treatment of various liver diseases, such as malignant tumors, benign tumors, hydatid disease, and abscesses. Despite technical advancements and tremendous experience in the field of liver resection of specialized centers, there are moderately high rates of postoperative morbidity and mortality, especially in high-risk and older patient populations. Although ultrasonography is usually the first-line imaging examination for postoperative complications, Computed Tomography (CT) is the imaging tool of choice in emergency settings due to its capability to assess the whole body in a few seconds and detect all possible complications. Magnetic resonance cholangiopancreatography (MRCP) is the imaging modality of choice for delineating early postoperative bile duct injuries and ischemic cholangitis that may arise in the late postoperative phase. Moreover, both MDCT and MRCP can precisely detect tumor recurrence. Consequently, radiologists should have knowledge of these surgical procedures for better comprehension of postoperative changes and recognition of the radiological features of various postoperative complications.

show abstract

Section: Complicationsmentioning

confidence: 99%

Imaging Features of Post Main Hepatectomy Complications: The Radiologist Challenging

et al. 2022

View full text Add to dashboard Cite

show abstract

“…[29][30][31] APT is considered an essential component of pharmacological management of PAD in multiple societies including the Society of Interventional Radiology (SIR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE), Society of Vascular Surgery (SVS), and American Heart Association (AHA). 3,8,32,33 Single APT with aspirin is commonly prescribed to reduce all cardiovascular risk, although this must be balanced with individual risk of bleeding. 34,35 Clopidogrel or ticagrelor monotherapy is indicated to reduce major adverse cardiovascular events (MACEs) in PAD patients.…”

Section: Antiplatelet Therapymentioning

confidence: 99%

Anticoagulation and Antiplatelet Agents in Peripheral Arterial Interventions

Taylor

Stiepel

Keefe

2022

Semin intervent Radiol

View full text Add to dashboard Cite

Effective revascularization of peripheral artery disease relies on periprocedural pharmacological regulation of the clotting cascade. Patient-specific factors such as cardiovascular risk factors, contraindications, and individual psychosocial factors must be considered when initiating post revascularization management. Management with anticoagulant and antiplatelet agents is discussed to guide the interventionalist on which therapy may be appropriate for their patient. While exact treatment may be institution and provider dependent, the interventionist must be familiar with the available classes of medications and how they can be prescribed in the postprocedural setting to improve cardiovascular outcomes.

show abstract

“…The management of oncological patients has changed profoundly and, although the main goal is overall survival (OS), new knowledge of the molecular cancer profile and the development of new pharmacologic treatments has led to the use of surrogate end-points to measure interim treatment efficacy [ 1 , 2 , 3 , 4 , 5 , 6 , 7 ] related to the disease setting, including disease-free (DF), recurrence-free (RF), and progression-free survival (PFS) [ 8 , 9 , 10 , 11 , 12 ]. In this context, interventional radiology (IR), especially ablation treatment, is one of the most rapidly growing areas in oncology [ 13 , 14 , 15 , 16 ]. Its success is essentially due to the minimally invasive nature of the treatment with lower complication rates and superior toxicity profiles, and often with comparable or superior mid- and long-term oncologic outcomes compared to conventional therapies, such as surgical procedures or systemic treatments [ 17 , 18 , 19 , 20 ].…”

Section: Introductionmentioning

confidence: 99%

Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect

Granata

Fusco

Muzio

et al. 2022

JCM

View full text Add to dashboard Cite

One of the major fields of application of ablation treatment is liver tumors. With respect to HCC, ablation treatments are considered as upfront treatments in patients with early-stage disease, while in colorectal liver metastases (CLM), they can be employed as an upfront treatment or in association with surgical resection. The main prognostic feature of ablation is the tumor size, since the goal of the treatment is the necrosis of all viable tumor tissue with an adequate tumor-free margin. Radiofrequency ablation (RFA) and microwave ablation (MWA) are the most employed ablation techniques. Ablation therapies in HCC and liver metastases have presented a challenge to radiologists, who need to assess response to determine complication-related treatment. Complications, defined as any unexpected variation from a procedural course, and adverse events, defined as any actual or potential injury related to the treatment, could occur either during the procedure or afterwards. To date, RFA and MWA have shown no statistically significant differences in mortality rates or major or minor complications. To reduce the rate of major complications, patient selection and risk assessment are essential. To determine the right cost-benefit ratio for the ablation method to be used, it is necessary to identify patients at high risk of infections, coagulation disorders and previous abdominal surgery interventions. Based on risk assessment, during the procedure as part of surveillance, the radiologists should pay attention to several complications, such as vascular, biliary, mechanical and infectious. Multiphase CT is an imaging tool chosen in emergency settings. The radiologist should report technical success, treatment efficacy, and complications. The complications should be assessed according to well-defined classification systems, and these complications should be categorized consistently according to severity and time of occurrence.

show abstract

CIRSE Clinical Practice Manual

Cited by 38 publications

References 94 publications

Imaging Features of Post Main Hepatectomy Complications: The Radiologist Challenging

Imaging Features of Post Main Hepatectomy Complications: The Radiologist Challenging

Anticoagulation and Antiplatelet Agents in Peripheral Arterial Interventions

Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect

Contact Info

Product

Resources

About